Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...

Senate version of Trump’s tax-cut bill “poses an existential threat to our hospitals and to the Medicaid and Medicare ...

Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...

The number of abortions in the U.S. rose again in 2024, with women continuing to find ways to get them despite bans and ...

WASHINGTON — Senate Republicans are considering adding a provision to President Trump’s tax cut bill that would further cut ...

Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass ...

Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination ...

WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the ...

And more health news stories you need to start your week.

Novo Nordisk is halting its collaboration with Hims & Hers Health over the sale of weight loss drugs, STAT says. The ...

Compass Pathways said Monday it achieved its primary endpoint in an early readout from the largest-ever study of psilocybin ...

But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...